Minnesota’s Generic Drug Pricing Law Paused by Federal Judge (1)

December 5, 2023, 7:34 PM UTCUpdated: December 5, 2023, 10:07 PM UTC

Minnesota must temporarily stop enforcing its law prohibiting certain price increases for generic drugs, a federal judge ruled in a win for the industry that claims the statute is a form of unconstitutional overreach.

The Association for Accessible Medicines, which represents generic and biosimilar manufacturers, is likely to succeed on its claim that the law violates the dormant Commerce Clause of the US Constitution because “it directly regulates transactions that take place wholly outside of Minnesota,” Judge Patrick J. Schiltz wrote Monday in his opinion for the US District Court for the District of Minnesota.

Schiltz temporarily enjoined Minnesota officials ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.